19.8.2019
News
M&A
TMT

KSB provided legal assistance to Solitea Group in the acquisition of the companies Dotykačka and Smart Software

KSB has provided comprehensive legal advice to the Solitea Group on the acquisition of a stake in the company Dotykačka and the acquisition of Smart Software, operating the Markeeta brand. The legal advice consisted mainly in the preparation and negotiation of acquisition contracts. Our legal services to Solitea included also advice on bank financing for the acquisitions referred to above.

As a result of these acquisitions, Solitea has significantly expanded its market share in the EET market, tripling the number of its accounting systems and becoming the market leader in this market.

The KSB team was led by partner Drahomír Tomašuk with further support of attorney Ján Béreš.

Other articles

8.7.2025
News

Advising J&T on the preparation of another bond programme – the Europacity Berlin project.

KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
News

A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein

Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
News

KŠB advised the seller on the sale of mcePharma to the Brenntag Group

The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.